Health hub

Women's Hair Loss: Minoxidil, Spironolactone, Laser Caps and Supplements, by the Evidence

Topical minoxidil has the best evidence for female pattern hair loss, and low-dose oral minoxidil matched it in a pooled analysis of trials. Spironolactone and laser caps have weaker data, and most hair supplements rest on small, short trials.

By Kymata Health editorial teamLast verified October 10, 2026

Medical review pending. Written by our editorial team from the studies and documents cited below; a credentialed clinician has not reviewed it yet. Educational only, not medical advice.

Key takeaways

  • In a Cochrane review of 47 trials, women using topical minoxidil were about twice as likely as placebo users to report moderate to marked regrowth [1].
  • Minoxidil 2% and 5% performed about the same in women [1]; the over-the-counter 5% foam for women is applied once daily, and results can take 3 to 6 months [2].
  • Oral and topical minoxidil gave similar hair density in a 2025 meta-analysis of 4 trials (279 people), with more unwanted hair growth on the oral form [3].
  • Laser combs raised hair counts vs sham devices in women [5], but in the Cochrane review women did not rate them better than sham [1].
  • Biotin can cause falsely low results on some troponin tests used to diagnose heart attacks [6].

Guides in this hub

  1. Minoxidil for Women: Topical Foam vs Low-Dose Pills, by the TrialsTopical minoxidil roughly doubled the odds of noticeable regrowth vs placebo in women. Low-dose oral minoxidil gave similar results in trials, with more unwanted hair growth, and it is off-label.
  2. Spironolactone for Female Pattern Hair Loss: What the Evidence ShowsSpironolactone is prescribed off-label for female pattern hair loss. Pooled studies suggest about half of women improve, but the studies vary widely and the drug needs potassium monitoring and is not for pregnancy.
  3. Hair Loss Supplements for Women: Biotin, Nutrafol and What the Trials ShowBiotin helps hair mainly in people who are deficient, and it can distort some lab tests. Branded supplements such as Nutrafol and Viviscal have small placebo-controlled trials, and a 2023 review called for bigger ones.

Where to start

Topical minoxidil is the treatment with the most consistent evidence for female pattern hair loss: in pooled trials it roughly doubled the chance of noticeable regrowth vs placebo, and the 5% strength was no better than 2% [1]. Our minoxidil guide compares the foam, the solution and low-dose tablets.

Minoxidil has to be used continuously; the drug facts label says hair loss will begin again if you stop, and that it will not work for all women [2].

Prescription options

Low-dose oral minoxidil is used off-label for hair loss; the tablets are FDA-approved only for severe high blood pressure and carry a warning about pericardial effusion at blood pressure doses [4]. Our minoxidil guide covers the safety data at hair-loss doses.

Spironolactone is another off-label option; our spironolactone guide covers what the studies show.

Laser caps and combs

In two sham-controlled trials of a laser comb in women, terminal hair counts rose by about 20 hairs per cm² over 26 weeks vs about 3 with the sham device [5]. The Cochrane review rated the hair-count evidence low quality and found women did not rate laser combs better than sham [1].

Kiierr's 148 and 272 laser caps were cleared through the FDA 510(k) pathway in September 2018 to promote hair growth in women with Ludwig-Savin I-II androgenetic alopecia [7].

Supplements

A 2023 systematic review found some supplements, including Nutrafol and Viviscal, had the higher-quality evidence among those studied, but trials were mostly small and the authors called for larger trials with active comparators [8]. Our supplements guide covers the trials and the biotin lab-test warning.

Partners we link to

Paid links: we earn a commission if you buy through these, at no extra cost to you. It never changes what the evidence sections say. Affiliate disclosure.

  • KiierrPaid linkLaser caps (148 and 272 diodes) cleared by the FDA in 2018 to promote hair growth in women with early female pattern hair loss (Ludwig-Savin I-II). Clearance is not a head-to-head comparison with minoxidil.See Kiierr laser caps

Regulatory and legal notes

  • Minoxidil tablets are FDA-approved only for severe, hard-to-control high blood pressure and carry a warning that they can cause pericardial effusion and worsen angina; low-dose use for hair loss is off-label [4].
  • The FDA warns that biotin, common in hair, skin and nail supplements, can cause falsely low results on certain troponin tests used to diagnose heart attacks, and lists assays that have not addressed the problem [6].
  • FDA 510(k) clearance of a laser cap means the device was found substantially equivalent to devices already on the market; Kiierr's clearance (K181878) covers women with Ludwig-Savin I-II hair loss [7].

Other names you will see

Listed for completeness. We have no paid relationship with these brands and do not link to them.

  • Nutrafol: Sells hair-growth supplements. Its women's formula was tested in a 40-woman, 6-month placebo-controlled trial [9]; see our supplements guide for the details.

References

  1. [1]Interventions for female pattern hair loss. Cochrane Database Syst Rev, 2016. PMID 27225981
  2. [2]Minoxidil for Women (minoxidil 5%) aerosol, foam: drug facts label. DailyMed, U.S. National Library of Medicine, 2026.
  3. [3]Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol, 2025. PMID 39425514
  4. [4]Minoxidil tablets: prescribing information. DailyMed, U.S. National Library of Medicine, 2026.
  5. [5]Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol, 2014. PMID 24474647
  6. [6]Biotin Interference with Troponin Lab Tests: Assays Subject to Biotin Interference. U.S. Food and Drug Administration, 2022.
  7. [7]510(k) Premarket Notification K181878: Kiierr 272 Laser, Kiierr 148 Laser. U.S. Food and Drug Administration, 2018.
  8. [8]Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatol, 2023. PMID 36449274
  9. [9]A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair. J Drugs Dermatol, 2018. PMID 29742189

Dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Prescription options need a licensed clinician. Talk to your clinician or pharmacist before starting anything new, especially if you take prescription medicines, are pregnant or breastfeeding.

Keep reading: Menopause and HRT

Menopause and HRT: every page →Women's hormone telehealth compared →Browse all topics →

Previous in this topicRecurrent Yeast Infections: Fluconazole, Boric Acid and Oteseconazole ComparedRecurrent yeast infection means three or more episodes in a year.Next in this topicMinoxidil for Women: Topical Foam vs Low-Dose Pills, by the TrialsTopical minoxidil roughly doubled the odds of noticeable regrowth vs placebo in women.Spironolactone for Female Pattern Hair Loss: What the Evidence ShowsSpironolactone is prescribed off-label for female pattern hair loss.Hair Loss Supplements for Women: Biotin, Nutrafol and What the Trials ShowBiotin helps hair mainly in people who are deficient, and it can distort some lab tests.Heavy Lifting After Menopause: What the LIFTMOR Trial Found for BoneIn women with low bone mass, 8 months of supervised heavy lifting and impact training raised spine and hip bone density and caused no vertebral fractures.

Menopause treatment cost →3 a.m. waking in menopause →Also in: Supplements and vitamins